Semler Scientific Stock News

Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Dennis Rosenberg - Chief Ma

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 24.32% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto

SANTA CLARA, Calif. , Oct. 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc

The Zacks Medical - Instruments industry is growing on R&D investments. SWAV, SMLR and ASXC are set to gain the most.

SANTA CLARA, Calif. , Aug. 31, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc

Investors cheered Semler's Q2 update.

Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary & Director Renae Cormier - He

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 27.50% and 0.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Semler Scientific's stock value has fallen from about $150 per share in November of 2021 to around $30 per share. Yet, the company continues to report growth and is profitable. I believe the market ha

SANTA CLARA, Calif. , July 21, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc

The company missed analysts' estimates with its Q1 results.

Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2022 Earnings Conference Call May 2, 2022 10:30 AM ET Company Participants Douglas Murphy-Chutorian - CEO Dennis Rosenberg - Chief Marketing Officer Andrew We

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of -19.61% and 5.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Semler Scientific has been sold off since its Q3 and Q4 earnings misses, down 67% from November 2021 levels. Semler is tackling massive healthcare problems such as PAD, diabetes, and Alzheimer's.

SANTA CLARA, Calif. , April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of health